Maximum quantity allowed is 999
Please select the quantity
CAS RN: 16676-29-2 | Product Number: N1176
Naltrexone Hydrochloride
×
![]()
×
Purity: >98.0%(GC)(HPLC)
Synonyms:
- Trexan
Product Documents:
| Size | Unit Price | Saitama (Kawaguchi) | Hyogo (Amagasaki) | Stock in other WH |
Shipping Information
|
|---|---|---|---|---|---|
| 250MG |
¥19,800
|
1 | 2 | 3 | |
| 1G |
¥59,500
|
1 | 2 | 8 |
* Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock In Other WH: Shipment in about 2-3 Business Days from Saitama warehouse. Please contact us
if you need further information.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | N1176 |
| Purity / Analysis Method | >98.0%(GC)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__0H__2__3NO__4·HCl = 377.87 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic,Heat Sensitive |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image), 250MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 16676-29-2 |
| Reaxys Registry Number | 3580333 |
| PubChem Substance ID | 468592499 |
| MDL Number | MFCD00069324 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Water | max. 11.0 % |
Properties (reference)
| Melting Point | 178 °C |
| Solubility in water | Soluble |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | QD2160000 |
Transport Information:
Application
Naltrexone Hydrochloride: A Long Acting Competitive Peripheral μ-Opioid Antagonist
Naltrexone hydrochloride, a long acting competitive peripheral μ-opioid antagonist, is a synthetic congener of opioid analgesics with little or no μ-opioid agonist properties.1) It is used for the treatment of opioid dependence and opioid-induced constipation, and is also used for alcohol dependence in US and EU.2,3) Recently, μ-opioid receptor is a potential target for cancer therapy because of its plausible role in tumor progression. Therefore, the μ-opioid antagonist naltrexone has received attention as a new anticancer agent with few side-effects (low-dose naltrexone, LDN).4,5) (The product is for research purpose only.)
References
- 1) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
- 2) Alteration of ethanol self-administration by naltrexone
- 3) Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence (a review)
- 4) The opioid growth factor-opioid growth factor receptor axis: Homeostatic regulator of cell proliferation and its implications for health and disease (a review)
- 5) Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.